|
 |
In this track attendees will have the opportunity to explore key themes in the development of mHealth solutions. These sessions will emphasize the introduction of new modalities, identification of opportunities for implementing interoperable devices and systems, and integration and collaboration with healthcare stakeholders. |
Monday, December 5th |
|
Session 1 |
12:00–1:00 PM |
The Benefits of Low Power, Short Range Wireless Health
Discussions around the promise of near-field communications have increased significantly over the past year as developers seek to demonstrate value of simplified transactions and data exchanges. But how practical are the implementations of this short-range modality in healthcare? Cutting through the veneer of recent hype, this session will showcase recent demonstrations and lessons learned from recent NFC deployments in healthcare.
| Moderator | |||||
 Suniti Ponkshe Sr. Executive Accenture |
 Sandra Elliott Director Meridian Health |
 Tarun Nimmagadda COO Mutual Mobile |
 Ketan Paranjape Chief of Staff Intel Corporation |
 John Peeters CEO www.gentag.com |
Session 2 |
2:00–3:00 PM |
Deployment of mHealth and System Infrastructure Implications
A consequence of increasingly sophisticated health delivery enterprises is complexity of existing infrastructure – technological, administrative, and political. In order to be successful, the underlying mHealth technology must be interoperable with a variety of organizational concerns at critical stages of deployment. By showcasing several cases studies in a variety of care settings, this session will discuss the infrastructure implications of mHealth that will guide the nature of deployment strategies.
| Moderator | |||||
 Arnaub Chatterjee Special Assistant Dept. of Health and Human Services |
 David Finn Health IT Officer Symantec |
 Jonathan Leidig Graduate Student Virginia Tech |
 Rajeev Rajan Sr. Dir, Product Mgmt. Qualcomm Inc. |
 Sweta Sneha Professor Kennesaw State University |
Session 3 |
3:15–4:15 PM |
Framing U.S. mHealth Development: How-to Align Function, Business, Policy, and Regulation
U.S. development and deployment of mHealth requires consideration of factors from the perspective of a range of diverse stakeholders. As mHealth policy and regulation evolves, new business models are emerging. Since the state-of-art of U.S. mHealth deployments is constantly evolving, oftentimes insight for successful private-sector models can be gained from public sector implementations that have addressed policy and regulatory considerations. This session showcases a variety of lessons learned from public-private mHealth deployments.
| Moderator | ||||||
 Brian Dolan Editor MobiHealthNews |
 Rick Cnossen Director, WW Health IT Program Office Intel |
 John Fessler CEO Santech, Inc. |
 Yael Harris Director HRSA |
 Jeanette Little Project Manager USAMRMC TATRC/Geneva Foundation |
Tuesday, December 6th |
|
Session 4 |
11:15 AM–12:15 PM |
Short-term Strategies for Fragmentation: Overcoming Interoperability Challenges Today
While significant strides in standards and policies have been made, interoperability remains an issue for both health IT and mHealth — be it between different healthcare systems between hospitals and government agencies, or even between separate apps in the same care setting. While the development of harmonized standards and robust platforms are compelling answers, they remain long-term solutions. In the interim, short- term strategies to overcome these challenges remain the best available options. Efforts to bridge interoperability gaps, in public and private settings, are presented in this session.
| Moderator | |||||
 Christopher Wasden Global Innovation Leader Pricewaterhouse Coopers |
 Bettina Experton CEO Humetrix |
 Mark Kramer Principal Engineer MITRE Corporation |
 Todd Plesko CEO EXTENSION, INC. |
 Tom Routen Consultant D-tree International |
Session 5 |
2:15–3:15 PM |
Encouraging Care Organizations and Payers to Become mHealth Testbeds
A difficult milestone for mHealth developers to reach is the validation of technology in a live setting. Developers typically need a care setting confirm the technology’s value proposition and business model, as well as to refine and improve functionality. Additionally, care organizations may find it challenging to appropriately screen and vet early stage technologies for testbed opportunities. This session offers a panel of speakers discussing the need and strategies for developing relationships leading to successful mHealth testbed opportunities.
| Moderator | |||||
 Pierce Graham-Jones Project Officer U.S. Dept. of Health and Human Services |
 Mark Cummings Research Professor Kennesaw State University |
 Annette Ghee Sr. Research Advisor in GH World Vision International |
 Ernesto Ramirez Doctoral Student University of California, San Diego |
 Martin Were Assistant Prof. of Medicine Indiana University |
